Reversing microtubule-directed chemotherapeutic drug resistance by co-delivering α2β1 inhibitor and paclitaxel with nanoparticles in ovarian cancer

通过纳米粒子共同递送 α2β1 抑制剂和紫杉醇来逆转卵巢癌微管导向化疗药物耐药性